These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


340 related items for PubMed ID: 22932083

  • 1. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
    Mu R, Sun XY, Lim LT, Xu CH, Dai CX, Su Y, Jia RL, Li ZG.
    Chin Med J (Engl); 2012 Aug; 125(16):2873-7. PubMed ID: 22932083
    [Abstract] [Full Text] [Related]

  • 2. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
    Wu O, Chen GP, Chen H, Li XP, Xu JH, Zhao SS, Sheng J, Feng JB, Cai J, Fang XH, Zhang WH, Li LH, Zhang N, Li J, Li JJ, Pan FM, Wang CZ, Ye DQ.
    Immunobiology; 2009 Aug; 214(5):392-402. PubMed ID: 19362685
    [Abstract] [Full Text] [Related]

  • 3. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, Takasaki Y.
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [Abstract] [Full Text] [Related]

  • 4. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC, Zhou QL, Li XZ, Yang JH, Ao X, Veeraragoo P, Zuo XX.
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [Abstract] [Full Text] [Related]

  • 5. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 6. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT.
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.
    Mortezagholi S, Babaloo Z, Rahimzadeh P, Namdari H, Ghaedi M, Gharibdoost F, Mirzaei R, Bidad K, Salehi E.
    Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):11-18. PubMed ID: 28049380
    [Abstract] [Full Text] [Related]

  • 8. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
    Lin LH, Ling P, Liu MF.
    J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
    [Abstract] [Full Text] [Related]

  • 9. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.
    Hermansen ML, Hummelshøj L, Lundsgaard D, Hornum L, Keller P, Fleckner J, Fox B, Poulsen LK, Jacobsen S.
    Lupus; 2012 Sep; 21(10):1098-104. PubMed ID: 22577117
    [Abstract] [Full Text] [Related]

  • 10. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
    Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL.
    J Exp Med; 2005 Oct 17; 202(8):1131-9. PubMed ID: 16230478
    [Abstract] [Full Text] [Related]

  • 11. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
    Chauhan SK, Singh VV, Rai R, Rai M, Rai G.
    J Clin Immunol; 2013 Jul 17; 33(5):954-64. PubMed ID: 23564191
    [Abstract] [Full Text] [Related]

  • 12. TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients.
    El-Karaksy SM, Kholoussi NM, Shahin RM, El-Ghar MM, Gheith Rel-S.
    Gene; 2013 Sep 15; 527(1):211-4. PubMed ID: 23792015
    [Abstract] [Full Text] [Related]

  • 13. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ, Rahman MA, Isenberg DA, Latchman DS.
    Arthritis Rheum; 2005 Apr 15; 52(4):1171-9. PubMed ID: 15818685
    [Abstract] [Full Text] [Related]

  • 14. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population.
    Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, Horiuchi T, Hisaeda H, Akira S, Kagami S, Yasutomo K.
    Ann Rheum Dis; 2007 Jul 15; 66(7):905-9. PubMed ID: 17344245
    [Abstract] [Full Text] [Related]

  • 15. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Zhu LJ, Yang X, Chen WY, Li XY, Ji YL, Mao HP, Nie J, Yu XQ.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3102-6. PubMed ID: 18269865
    [Abstract] [Full Text] [Related]

  • 16. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.
    Arthritis Rheum; 2005 May 27; 52(5):1491-503. PubMed ID: 15880830
    [Abstract] [Full Text] [Related]

  • 17. Toll-like receptor expression in lupus peripheral blood mononuclear cells.
    Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H, Kimura H, Ishibashi H, Eguchi K.
    J Rheumatol; 2007 Mar 27; 34(3):493-500. PubMed ID: 17295441
    [Abstract] [Full Text] [Related]

  • 18. Correlation between TLR9 Expression and Cytokine Secretion in the Clinical Diagnosis of Systemic Lupus Erythematosus.
    Rao H, Zeng Q, Liang Y, Xiao C, Xie S, Xu X.
    Mediators Inflamm; 2015 Mar 27; 2015():710720. PubMed ID: 26457008
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M, Kim D, Oh M, Jeong H, Choi I.
    Lupus; 2009 May 27; 18(6):501-7. PubMed ID: 19395451
    [Abstract] [Full Text] [Related]

  • 20. Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females.
    Laska MJ, Troldborg A, Hansen B, Stengaard-Pedersen K, Junker P, Nexø BA, Voss A.
    Rheumatology (Oxford); 2014 Jan 27; 53(1):48-55. PubMed ID: 24064706
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.